Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. (GU5)
FSX
Closed
Aug 24, 2026
Day's Range
1.5152 wk Range
1.51Overview - GU5 - Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
Key Statistics
Valuation
Enterprise Value
1.40B
P/E (Trailing)
‪7.00‬
Price / Sales (TTM)
‪0.03‬
Price / Book
‪0.51‬
EV / EBITDA
‪2.86‬
Profitability
Gross Margin
‪20.31%‬
Profit Margin
‪3.75%‬
Operating Margin
‪9.34%‬
Return on Assets
‪2.36%‬
Return on Equity
‪7.42%‬
Ownership
Shares Outstanding
1.62B
Float
872.95M
Held by Insiders
‪0.00%‬
Held by Institutions
‪25.36%‬
Price stats
Beta
‪0.18‬
50-Day Avg
‪1.66‬
200-Day Avg
‪1.86‬
Dividends
Payout Ratio
‪44.14%‬
Frequency
Annual
Market Cap - GU5 - Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
Peers - GU5 - Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
Peer Comparison
Compared with companies in Medical Distribution listed on FSX.
Profile Summary - GU5 - Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
About
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. is a key player in the pharmaceutical industry, primarily involved in the research, development, manufacturing, and distribution of an extensive range of healthcare products. Its product portfolio includes traditional Chinese medicines, chemical pharmaceuticals,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
